Cannabidiol, a non-psychotropic plant-derived cannabinoid, decreases inflammation in a murine model of acute lung injury: Role for the adenosine A2A receptor
Alison Ribeiro(Universidade de São Paulo), João Palermo‐Neto(Universidade de São Paulo), A.T. Akamine(Universidade de São Paulo), José Alexandre S. Crippa(Universidade de São Paulo), Domenica Palomaris Mariano-Souza(Universidade Federal do Tocantins), V. Ferraz-de-Paula(Universidade de São Paulo), Luana Beatriz Vitoretti(Universidade de São Paulo), Antônio Waldo Zuardi(Universidade de São Paulo), Felipe Dal‐Pizzol, João Quevedo(The University of Texas MD Anderson Cancer Center), Jaime E. C. Hallak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Vinicius Izidio de Almeida(Universidade de São Paulo), W.M. Quinteiro-Filho(Universidade de São Paulo), M.L. Pinheiro(Universidade de São Paulo)
Cited by 188
Related Papers
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
|Journal of Psychopharmacology|2010|530
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
|Brazilian Journal of Psychiatry|2015|484
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
|Journal of Clinical Psychopharmacology|2015|465